IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Ganga Pharmaceuticals IPO is a Fixed Price listing on BSE SME exchange, with an ipo size of ₹ 1.54 Cr. The company is based in Mumbai and caters to Pharmaceutical - Ayurvedic sector. First Overseas Capital is the merchant banker of Ganga Pharmaceuticals IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 24th September 2015.
Ganga Pharmaceuticals IPO posted revenues of ₹ 2.58 Cr. and PAT of ₹ 0.48 Cr. in FY16 on annualised basis.
Revenue:
₹ 2.58 Cr.
EBITDA Margin:
3.88
% 
Net Worth: ₹ 3.26 Cr.
Market Capitalisation:
[●]
P/E:
65.00 times
P/BV: [●]
EV/EBITDA: 18.80 times
Financial results of Ganga Pharmaceuticals IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Sep-15 | FY15 | FY14 | FY13 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 5.93 | 5.39 | 5.14 | 4.78 | |
| Net Worth | 3.26 | 2.64 | 2.60 | 2.35 | |
| Total Debt | 2.00 | 2.14 | 2.07 | 1.64 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
1.29
2.58 |
2.69 | 2.66 | 2.31 | |
EBITDA
EBITDA on annualised basis |
0.05
0.10 |
0.03 | 0.03 | 0.03 | |
PAT
PAT on annualised basis |
0.24
0.48 |
0.42 | 0.37 | 0.36 | |
Ganga Pharmaceuticals IPO PAT Margin is 18.60 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Ganga Pharmaceuticals IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Sep-15 | FY15 | FY14 | FY13 |
|---|---|---|---|---|
| EBITDA Margin (%) | 3.88 | 1.12 | 1.13 | 1.30 |
| PAT Margin (%) | 18.60 | 15.61 | 13.91 | 15.58 |
| EPS (₹) | [●] | 0.14 | 0.13 | 0.11 |
| ROE (%) | 7.36 | 15.91 | 14.23 | 15.32 |
| ROCE (%) | [●] | [●] | [●] | [●] |
| ROA (%) | 4.05 | 7.79 | 7.20 | 7.53 |
| Debt to Equity | 0.61 | 0.81 | 0.80 | 0.70 |
The market Capitalisation of Ganga Pharmaceuticals IPO is ₹ 0.00 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Ganga Pharmaceuticals IPO prospectus highlights an Return on Equity (ROE) of 7.36 % , Return on Assets (ROA) of 4.05 %, and an EBITDA Margin of 3.88 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Ganga Pharmaceuticals IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Ganga Pharmaceuticals IPO is ₹ 0.00 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Ganga Pharmaceuticals IPO has a Price-to-Earnings (PE) ratio of 65.00 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Ganga Pharmaceuticals IPO reported revenue of ₹ 2.58 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Ganga Pharmaceuticals IPO provide insights into sales growth, market demand, and business scalability.
Ganga Pharmaceuticals recorded an EBITDA of ₹ 0.10 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Ganga Pharmaceuticals Profit After Tax (PAT) is ₹ 0.48 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 2.58 Cr.
EBITDA Margin:
3.88
%
Net Worth: ₹ 3.26 Cr.
Market Capitalisation:
[●]
P/E:
65.00 times
P/BV: [●]
EV/EBITDA:
[●]
Ganga Pharmaceuticals operates in Pharmaceutical - Ayurvedic and Marketing Distribution Of Bulk Ayurvedic Medicines. The Issue is listed on BSE SME in Feb, 2016. Ganga Pharmaceuticals IPO size was 1.54 with Issue price of 15.00 .
Merchant Banker(s) of Ganga Pharmaceuticals IPO: First Overseas Capital Limited
Ganga Pharmaceuticals IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Ganga Pharmaceuticals IPO listed at a listing price of 14.50 against the offer price of 15.00.
The current market price of Ganga Pharmaceuticals is 14.80.
Why Us?
